Earlier this week, ResMed (NYSE:RMD) reported that it will release its quarterly earnings on Thursday afternoon, with Wall Street expecting around 10% year-on-year revenue growth and earnings of about ...
Columnist Ben Hofmeister was all set for a colonoscopy, but concerns about MS-related breathing issues put it on the back burner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results